Bentham Science Logo

Recent Patents on Anti-Cancer Drug Discovery

Volume 14, 4 Issues, 2019
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Ranking and Category

  • 173rd of 229 in

    Oncology

  • 171st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 14

-

Number 2



Biography   Open Access



Review Article



Review Article



Review Article

Cucurbitacins as Anticancer Agents: A Patent Review

, 14(2): 133 - 143

Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi F. Khattak, Muhammad Irshad and Maroof Ali


DOI: 10.2174/1574892813666181119123035


Review Article   Open Access



Research Article

A Truncated Snail1 Transcription Factor Alters the Expression of Essential EMT Markers and Suppresses Tumor Cell Migration in a Human Lung Cancer Cell Line

, 14(2): 158 - 169

Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*


DOI: 10.2174/1574892814666190527111429


Research Article



Research Article

Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK

, 14(2): 177 - 186

Yingfang Fan, Najia Mansoor*, Tasneem Ahmad, Zhuo X. Wu, Rafeeq A. Khan, Martin Czejka, Syed Sharib, Mansoor Ahmed, Zhe S. Chen and Dong H. Yang*


DOI: 10.2174/1574892814666190212164356


Articles Ahead of Print

There are currently no Articles Ahead of Print available for this journal.

Abstracts Ahead of Print

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer


Emanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, Giulia Fornasier, Elisa Giacomin, Francesco Lo Re, Paolo Baldo*, Giuseppe Corona and Carlo Gobitti


DOI: 10.2174/1574892814666190726143011
View Abstract


Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma


Debora Basile*, Camilla Lisanti*, Maria A. Pizzichetta*, Paolo Baldo*, Giulia Fornasier, Francesco Lo Re, Giuseppe Corona and Fabio Puglisi*


DOI: 10.2174/1574892814666190726130351
View Abstract


Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer


Alessandra Bearz, Sara Cecco, Sara Francescon, Francesco Lo Re, Giuseppe Corona and Paolo Baldo*


DOI: 10.2174/1574892814666190726124735
View Abstract


Published Contents

Editor's Choice


Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256







Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

, 2017; 12(3): 190 - 207

Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*


DOI: 10.2174/1574892812666170619125503





Open Access Articles


From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70 - 84

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*





New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53 - 59

Paolo Chieffi*, Marco De Martino and Francesco Esposito




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*




Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 2019; 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*




Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment

, 2019; 14(1): 32 - 38

Giorgia Scarpellino, Tullio Genova and Luca Munaron*




Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

, 2019; 14(1): 19 - 31

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*




Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*





Most Cited Articles

Review Article

Use of human dihydroorotate dehydrogenase (hDHODH) inhibitors in autoimmune diseases and new perspectives in cancer therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*


DOI: 10.2174/1574892812666171108124218


Review Article

Advances in the discovery of anthraquinone-based anticancer agents

, 2018; 13(2): 159-183.

Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin


DOI: 10.2174/1574892813666171206123114


Review Article

PARP inhibitors in ovarian cancer

, 2018; 13(4): 392-410.

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256


Review Article

Anti-oxidants as chemopreventive agents in prostate cancer: A gap between preclinical and clinical studies

, 2018; 13(2): 224-239.

Monireh Mohsenzadegan*, Farhad Seif, Mohammad M. Farajollahi and Majid Khoshmirsafa


DOI: 10.2174/1574892813666180213164700


Review Article

PARP inhibitors in epithelial ovarian cancer

, 2018; 13(2): 145-158.

Kristin N. Taylor and Ramez N. Eskander*


DOI: 10.2174/1574892813666171204094822


Review Article

Targeting mevalonate pathway in cancer treatment: Repurposing of statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211


Review Article

Nucleic acid sensing machinery: Targeting innate immune system for cancer therapy

, 2018; 13(1): 2-17.

Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*


DOI: 10.2174/1574892812666171030163804



Review Article

Adenosine receptor ligands on cancer therapy: A review of patent literature

, 2018; 13(1): 40-69.

Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves


DOI: 10.2174/1574892812666171108115959




Review Article

Recent progress of marine polypeptides as anticancer agents

, 2018; 13(4): 445-454.

Lanhong Zheng, Yixin Xu, Xiukun Lin*, Zhixin Yuan, Minghua Liu, Shousong Cao, Fuming Zhang and Robert J. Linhardt


DOI: 10.2174/1574892813666180430110033


Review Article

Anaplastic lymphoma kinase in glioblastoma: Detection/diagnostic methods and therapeutic options

, 2018; 13(2): 209-223.

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*


DOI: 10.2174/1574892813666180115151554





Most Accessed Articles


Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents

, 2019; 14(1): 85-94.

Maricruz Anaya-Ruiz, Cindy Bandala, Gerardo Landeta, Patricia Martínez-Morales, Jose L. Zumaquero-Rios, Jorge Sarracent-Pérez and Martín Pérez-Santos*


DOI: 10.2174/1574892813666181031154146



Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827


Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211


New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito


DOI: 10.2174/1574892814666190111120023



Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*


DOI: 10.2174/1574892812666171108124218


From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*


DOI: 10.2174/1574892814666190119165157




Related Journals

Related eBooks

eBooks Catalog